Furthermore, many of these circulating biomarkers including NGAL, TM and NT-proBNP are elevated in patients with CKD and appear to rise contemporaneously with a drop in GFR.39–41 Thus, their interpretation in this setting may be unclear as elevated levels may not necessarily reflect increased production but rather a prolonged half-life caused by impaired clearance. Here, NPPB is linked to chronic kidney disease.